Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants
Condition(s):Breast NeoplasmsLast Updated:March 9, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Breast NeoplasmsLast Updated:March 9, 2023Recruiting
Condition(s):Breast NeoplasmLast Updated:March 7, 2023Completed
Condition(s):Breast CancerLast Updated:February 7, 2017Terminated
Condition(s):Radiotherapy Side Effect; Locoregional RecurrenceLast Updated:September 16, 2020Unknown status
Condition(s):Breast Cancer; Upper Extremity Dysfunction; Tissue AdhesionLast Updated:August 24, 2023Not yet recruiting
Condition(s):Breast CancerLast Updated:February 1, 2021Completed
Condition(s):Women’s Health: Neoplasm of BreastLast Updated:May 24, 2023Active, not recruiting
Condition(s):Breast Cancer, Early-OnsetLast Updated:July 28, 2021Completed
Condition(s):CancerLast Updated:September 14, 2018Completed
Condition(s):Breast Neoplasm Malignant PrimaryLast Updated:February 15, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.